|
|
Volumn 45, Issue 9, 1996, Pages 435-437
|
|
Ion channel modulation as a drug discovery target in inflammatory diseases
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3,4 DIHYDRO 2,2 DIMETHYL 4 (2 OXO 1 PIPERIDINYL) 6 PENTAFLUOROETHYL 2H 1 BENZOPYRAN 3 OL;
4 BENZHYDRYLOXYMETHYL 1 [3 (4 METHOXYPHENYL)PROPYL]PIPERIDINE;
4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID;
ADENOSINE TRIPHOSPHATE;
ANTIINFLAMMATORY AGENT;
CHLORIDE CHANNEL;
FLUFENAMIC ACID;
N (4 BENZOYLPHENYL) 3,3,3 TRIFLUORO 2 HYDROXY 2 METHYLPROPIONAMIDE;
N (4 CHLOROPHENYL) N' CYANO N'' (6 CYANO 3,4 DIHYDRO 3 HYDROXY 2,2 DIMETHYL 2H 1 BENZOPYRAN 4 YL)GUANIDINE;
NIFLUMIC ACID;
PIPERIDINE DERIVATIVE;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL BLOCKING AGENT;
SULFONYLUREA;
UNCLASSIFIED DRUG;
ASTHMA;
AUTOIMMUNITY;
CELL PROLIFERATION;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SELECTIVITY;
DRUG TARGETING;
GRAFT REJECTION;
HUMAN;
INFLAMMATION;
NONHUMAN;
PROTEIN ANALYSIS;
T LYMPHOCYTE ACTIVATION;
|
|
EID: 0029823927
PISSN: 10233830
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02252312 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
